This is a well-structured, pragmatic plan. Here's my honest assessment:
What Works Well
The core philosophy is sound. Studying preclinicals through clinical context rather than as isolated subjects is exactly how knowledge sticks. A Year 3 student who understands why Frank-Starling matters in heart failure will retain it far better than one who memorized it for a physiology exam.
The sequencing is logical. Starting with General Pathology is the right call - cell injury, inflammation, and healing are the "operating system" that everything else runs on. Once you understand inflammation properly, immunology becomes revision rather than new learning.
The 80/20 principle is correctly applied. The topics selected are genuinely high-yield for clinical work. You haven't included renal tubular physiology minutiae or obscure pharmacokinetic equations - the omissions are deliberate and correct.
Gaps and Risks to Address
1. The timeline is optimistic, not realistic.
Day 1-2 for General Pathology covers 9 major topics. Neoplasia alone (cell cycle, oncogenes, tumour suppressor genes, staging, grading, metastasis) is a full day at meaningful depth. If you rush it, you'll end up with surface-level understanding that won't survive clinical questioning. Consider either:
- Splitting General Pathology into 3 days, or
- Being ruthless: do cell injury + inflammation + healing on Day 1, then thrombosis/embolism/shock/neoplasia on Day 2 without touching anything else
2. Immunology in one day is the weakest link.
This is your stated weakest subject and you've given it one day. Hypersensitivity I-IV + autoimmunity + HIV + vaccines in a single sitting will produce shallow pattern recognition at best. Given your clinical list includes SLE, rheumatic fever, and Kawasaki - all of which require genuine immunological reasoning - this deserves Day 3 and Day 4, with Day 4 being a bridge into clinical immunology (complement, ANA patterns, ANCA, etc.).
3. Pharmacology Phase 2 has no timeline.
Phase 1 is Day 1-8. Phase 2 (Clinical Pharmacology) has no day allocations at all. This creates a planning gap - when your CA is August-end, you need to know exactly how many days Phase 2 and Phase 3 will take so you can work backwards from the exam date.
4. Acid-base appears twice but never completely.
You introduce acid-base basics in Respiratory Physiology (Day 6) and acid-base regulation in Renal Physiology (Day 7). This split is fine conceptually, but in practice students end up half-understanding it in both sessions. Better to fully complete acid-base on Day 7 and just reference it on Day 6.
5. Phase 3 Anatomy needs clinical anchoring too.
You've done this well for Phases 1 and 2 but Phase 3 lists anatomy topics without clinical correlations. Add them explicitly:
- Brachial plexus → Erb's palsy, Klumpke's, Saturday night palsy
- Inguinal canal → direct vs indirect hernia, laparoscopic repair landmarks
- Fetal skull → instrumental delivery, moulding, CPD
Without the clinical peg, anatomy revision feels abstract and is harder to recall under exam pressure.
6. Neurology is underweighted in the preclinical phase.
Your clinical list includes stroke, epilepsy, and Bell's palsy, but there's no neurophysiology or neuropathology in Phase 1. Even a half-day on:
- Neurotransmitters (dopamine, ACh, GABA, serotonin)
- Action potentials and synaptic transmission
- Blood-brain barrier
...would significantly improve your pharmacology understanding (anticonvulsants, antidepressants, antipsychotics) and your clinical neurology reasoning.
Suggested Adjustments
| Phase 1 (Revised) | Days |
|---|
| General Pathology | 3 days |
| Immunology | 2 days |
| CVS Physiology | 2 days |
| Respiratory Physiology | 1 day |
| Renal Physiology + Acid-base (complete) | 1 day |
| Pharmacology Basics + Neuro basics combined | 1 day |
| Total | ~10 days |
Then assign explicit day counts to Phase 2 and Phase 3, and reverse-engineer from your August exam date to see if it's feasible.
One Practical Suggestion
For each topic in Phase 1, use this structure instead of reading chapters linearly:
- What goes wrong? (the pathology/disease)
- Why does it go wrong? (the mechanism - physiology, biochemistry)
- What do we do about it? (the drug/intervention)
- What does it look like? (the clinical presentation)
This keeps every preclinical concept tied to a clinical outcome and prevents the drift back into textbook-style learning.
Overall verdict: This is a genuinely good plan that most Year 3 students would benefit from. The philosophy is right. The main corrections needed are timeline realism (especially immunology), explicit day-allocation for Phases 2 and 3, and adding a neuroscience component. Fix those and you have a solid 6-week pre-CA framework.